Myriad Genetics
MYGN
#6699
Rank
โ‚น59.37 B
Marketcap
โ‚น636.94
Share price
-3.27%
Change (1 day)
-54.03%
Change (1 year)

Myriad Genetics (MYGN) - Total assets

Total assets on the balance sheet as of September 2025 : โ‚น65.40 Billion

According to Myriad Genetics's latest financial reports the company's total assets are โ‚น65.40 Billion. A companyโ€™s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.

Myriad Genetics - Total assets on balance sheet (from 2001 to 2025)

Total assets by year

Year Total assets Change
2024-12-31โ‚น88.15 B-7.64%
2023-12-31โ‚น95.44 B-3.78%
2022-12-31โ‚น99.19 B0.91%
2021-12-31โ‚น98.30 B
2020-06-30โ‚น106.39 B-1.24%
2019-06-30โ‚น107.73 B33.92%
2018-06-30โ‚น80.44 B2.98%
2017-06-30โ‚น78.11 B31.44%
2016-06-30โ‚น59.43 B21.99%
2015-06-30โ‚น48.72 B-1.38%
2014-06-30โ‚น49.40 B3.25%
2013-06-30โ‚น47.84 B24.81%
2012-06-30โ‚น38.33 B40.75%
2011-06-30โ‚น27.23 B-1.17%
2010-06-30โ‚น27.56 B23.49%
2009-06-30โ‚น22.31 B4.13%
2008-06-30โ‚น21.43 B40.8%
2007-06-30โ‚น15.22 B18.76%
2006-06-30โ‚น12.81 B85.36%
2005-06-30โ‚น6.91 B-19.82%
2004-06-30โ‚น8.62 B1.76%
2003-06-30โ‚น8.47 B10.16%
2002-06-30โ‚น7.69 B-4.95%
2001-06-30โ‚น8.09 B

Total Assets for similar companies or competitors

Company Total assets differencediff. Country
Bio-Rad Laboratories
BIO
โ‚น871.08 B 1,231.74%๐Ÿ‡บ๐Ÿ‡ธ USA
Exact Sciences
EXAS
โ‚น530.03 B 710.33%๐Ÿ‡บ๐Ÿ‡ธ USA
Biocept
BIOC
โ‚น1.98 B-96.96%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
โ‚น684.09 B 945.85%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
โ‚น7.562 T 11,461.74%๐Ÿ‡บ๐Ÿ‡ธ USA